Elevated levels of inflammatory mediators have been identified in patients with heart failure,
including heart failure with reduced and preserved ejection fraction, as well as acute …

Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …

Epidemiology is the study of the distribution and determinants of disease in human
populations. Over the past decade there has been considerable progress in our …

Rheumatoid arthritis (RA) is often characterized by the burden of swollen joints, pain, and
decreased physical function, but less understood are the many manifestations of additional …

Patients with rheumatoid arthritis (RA) are at increased risk of mortality compared with the
general population. Evidence suggests that this increased mortality can largely be attributed …

Chronic inflammatory rheumatic diseases (IRD), including rheumatoid arthritis, ankylosing
spondylitis, and psoriatic arthritis, are prevalent conditions worldwide, with a considerable …

Objective To examine the association of serum inflammatory markers (erythrocyte
sedimentation rate (ESR) and C-reactive protein (CRP)) and serum lipid measures (low …

Background: It is unknown whether the increased risk of heart failure (HF) in rheumatoid
arthritis (RA) is independent of ischemic heart disease (IHD). Objectives: This study sought …

Background: Findings regarding the prevalence of vascular comorbidities in multiple
sclerosis (MS) are conflicting. Objective: The objective of this review is to estimate the …

Objective To estimate the 10‐year absolute risk of cardiovascular (CV) events in newly
diagnosed rheumatoid arthritis (RA) patients and the potential contribution of CV risk factors …